BNTX
BioNTech SE ADR
3월 13일 4:00 PM ET (한국 3/14 05:00)
$91.19
+1.09 ▲ +1.21%
🌙 3월 13일 7:59 PM ET (한국 3/14 08:59)
$91.28
+0.09 ▲ +0.10%
| Index | - | P/E | - | EPS (ttm) | -5.23 | Insider Own | 0.37% | Shs Outstand | 0.25B | Perf Week | -10.16% |
| Market Cap | 22.92B | Forward P/E | - | EPS next Y | -2.41% | Insider Trans | - | Shs Float | 0.25B | Perf Month | -16.63% |
| Enterprise Value | 5.80B | PEG | - | EPS next Q | -2.53 | Inst Own | 19.9% | Short Float | 1.78% | Perf Quarter | -4.75% |
| Income | -1.26B | P/S | 6.9 | EPS this Y | 17.14% | Inst Trans | -1.6% | Short Ratio | 3.68 | Perf Half Y | -12.58% |
| Sales | 3.32B | P/B | 1.02 | EPS next 5Y | 21.21% | ROA | -5.14% | Short Interest | 4.46M | Perf YTD | -4.21% |
| Book/sh | 89.84 | P/C | 1.31 | EPS past 3/5Y | - | ROE | -5.93% | 52W High | -26.46% ($124.00) | Perf Year | -6.44% |
| Cash/sh | 69.35 | P/FCF | 72.02 | Sales past 3/5Y | -43.74% 42.57% | ROIC | -5.54% | 52W Low | 14.68% ($79.52) | Perf 3Y | -29.73% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -73.28% | Gross Margin | 77.82% | Volatility(W/M) | 4.75% 3.46% | Perf 5Y | -10.52% |
| Dividend TTM | - | EV/Sales | 1.75 | Sales Y/Y TTM | 11.42% | Oper. Margin | -21.78% | ATR (14) | 4.86 | Perf 10Y | - |
| Dividend Ex-Date | 2022/6/2 | Quick Ratio | 7.49 | EPS Q/Q | -225.53% | Profit Margin | -38.09% | RSI (14) | 35.98 | Recom | 1.57 |
| Dividend Gr. 3/5Y | - | Current Ratio | 7.54 | Sales Q/Q | -16.8% | SMA20 | -11.67% ($103.24) | Beta | 1.57 | Target Price | $132.99 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 3000000 | SMA50 | -13.95% ($105.97) | Rel Volume | 1.16 | Prev Close | $90.1 |
| Employees | 7807 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | -663.1% 16.52% | SMA200 | -12.88% ($104.67) | Avg Volume(3M) | 1.21M | Price | $91.19 |
| IPO | 2019/10/10 | Option/Short | Yes/Yes | Trades | 13899 | Volume | 1,407,398 | Change | 1.21% |
뉴스 로딩 중...